These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6723005)

  • 1. The spontaneous occurrence of paroxysmal supraventricular tachycardia.
    Pritchett EL; Smith MS; McCarthy EA; Lee KL
    Circulation; 1984 Jul; 70(1):1-6. PubMed ID: 6723005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical behavior of paroxysmal atrial tachycardia.
    Pritchett EL; McCarthy EA; Lee KL
    Am J Cardiol; 1988 Aug; 62(6):3D-9D. PubMed ID: 3407600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia.
    Pritchett EL; Hammill SC; Reiter MJ; Lee KL; McCarthy EA; Zimmerman JM; Shand DG
    Am J Cardiol; 1983 Nov; 52(8):1007-12. PubMed ID: 6356859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
    Clair WK; Wilkinson WE; McCarthy EA; Page RL; Pritchett EL
    Circulation; 1993 Apr; 87(4):1114-22. PubMed ID: 8462140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial.
    Mauritson DR; Winniford MD; Walker WS; Rude RE; Cary JR; Hillis LD
    Ann Intern Med; 1982 Apr; 96(4):409-12. PubMed ID: 7065555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous diltiazem hydrochloride rather than verapamil for resistant paroxysmal supraventricular tachycardia.
    Peitz TJ
    West J Med; 1993 Nov; 159(5):598-9. PubMed ID: 8279162
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous diltiazem for the treatment of supraventricular tachycardia.
    Sternbach GL; Schroeder JS; Eliastam M; Beier-Scott L
    Clin Cardiol; 1986 Apr; 9(4):145-9. PubMed ID: 3720041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias.
    Pritchett EL; Lee KL
    J Clin Epidemiol; 1988; 41(9):851-8. PubMed ID: 3183691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diltiazem in paroxysmal supraventricular tachycardia: electrocardiographic findings at termination].
    De Rosa F; Mancuso P; Misuraca G; Serafini O; Filice E; Fascetti F; Battista F; Plastina F
    G Ital Cardiol; 1992 Oct; 22(10):1145-9. PubMed ID: 1291409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial.
    Shaker H; Jahanian F; Fathi M; Zare M
    Ther Adv Cardiovasc Dis; 2015 Feb; 9(1):4-9. PubMed ID: 25297337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
    Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination of paroxysmal supraventricular tachycardia with oral diltiazem.
    Pauszek ME
    Indiana Med; 1991 May; 84(5):318-20. PubMed ID: 2061599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian occurrence of symptomatic paroxysmal supraventricular tachycardia in untreated patients.
    Irwin JM; McCarthy EA; Wilkinson WE; Pritchett EL
    Circulation; 1988 Feb; 77(2):298-300. PubMed ID: 3338126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N; Penev A; Kaponov Kh
    Vutr Boles; 1984; 23(1):63-9. PubMed ID: 6730453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal Supraventricular Tachycardia: Pathophysiology, Diagnosis, and Management.
    Al-Zaiti SS; Magdic KS
    Crit Care Nurs Clin North Am; 2016 Sep; 28(3):309-16. PubMed ID: 27484659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
    DiMarco JP; Miles W; Akhtar M; Milstein S; Sharma AD; Platia E; McGovern B; Scheinman MM; Govier WC
    Ann Intern Med; 1990 Jul; 113(2):104-10. PubMed ID: 2193560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ; Gulamhusein S; Prystowsky EN; Carruthers SG; Donner AP; Ko PT
    Am J Cardiol; 1982 Jan; 49(1):117-24. PubMed ID: 7053599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.